Shanghai Pharma targets Aussie vitamin maker

The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products.

Shanghai Pharma targets Aussie vitamin maker

China's insatiable appetite for all things Australian has seen it snap up everything from natural resources and real estate to airlines, hospitals and dairy farms. Vitamins are now on the list, too.

Shanghai Pharmaceuticals announced on Thursday it was teaming up with Chinese private equity firm Primavera Capital to acquire Sydney-listed Vitaco Holdings for A$314 million $238 million, just 10 months after the vitamins and health supplement maker made its debut on the...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES

  • Green Bonds Southeast Asia

    25 May 2017  |  Singapore
    With Green Bonds globally reaching USD200 billion outstanding in 2016, from as little as 30bn just 4 years ago, can SE Asia corporations and ...
  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...